The EPISTENT trial at 6 months: Relative and combined effects of abciximab and stenting on reduction of acute ischemic events and late revascularization
Publication
, Journal Article
Lincoff, AM; Tcheng, JE; Califf, RM; Cabot, CF; Booth, JE; Godfrey, NK; Topol, EJ
Published in: CIRCULATION
October 27, 1998
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 27, 1998
Volume
98
Issue
17
Start / End Page
767 / 767
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lincoff, A. M., Tcheng, J. E., Califf, R. M., Cabot, C. F., Booth, J. E., Godfrey, N. K., & Topol, E. J. (1998). The EPISTENT trial at 6 months: Relative and combined effects of abciximab and stenting on reduction of acute ischemic events and late revascularization. CIRCULATION, 98(17), 767–767.
Lincoff, A. M., J. E. Tcheng, R. M. Califf, C. F. Cabot, J. E. Booth, N. K. Godfrey, and E. J. Topol. “The EPISTENT trial at 6 months: Relative and combined effects of abciximab and stenting on reduction of acute ischemic events and late revascularization.” CIRCULATION 98, no. 17 (October 27, 1998): 767–767.
Lincoff AM, Tcheng JE, Califf RM, Cabot CF, Booth JE, Godfrey NK, et al. The EPISTENT trial at 6 months: Relative and combined effects of abciximab and stenting on reduction of acute ischemic events and late revascularization. CIRCULATION. 1998 Oct 27;98(17):767–767.
Lincoff, A. M., et al. “The EPISTENT trial at 6 months: Relative and combined effects of abciximab and stenting on reduction of acute ischemic events and late revascularization.” CIRCULATION, vol. 98, no. 17, LIPPINCOTT WILLIAMS & WILKINS, Oct. 1998, pp. 767–767.
Lincoff AM, Tcheng JE, Califf RM, Cabot CF, Booth JE, Godfrey NK, Topol EJ. The EPISTENT trial at 6 months: Relative and combined effects of abciximab and stenting on reduction of acute ischemic events and late revascularization. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 1998 Oct 27;98(17):767–767.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 27, 1998
Volume
98
Issue
17
Start / End Page
767 / 767
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology